[YMAB] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
29-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 0.00%
YoY-
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 20,751 10,797 10,951 0 0 0 0 -
PBT -6,123 -41,131 -22,937 -40,393 -18,036 -10,305 -3,041 12.36%
Tax 179 1,186 -216 0 0 0 23 40.75%
NP -6,302 -42,317 -22,937 -40,393 -18,036 -10,305 -3,041 12.90%
Tax Rate - - - - - - - -
Total Cost 27,053 53,114 33,888 40,393 18,036 10,305 3,041 43.92%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -30.37 -391.93 -209.45 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.14 -0.97 -0.53 -1.01 -0.53 -0.32 -0.17 -3.18%
EPS Diluted -0.14 -0.97 -0.53 -1.01 -0.53 -0.32 -0.17 -3.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.